JP2003511450A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003511450A5 JP2003511450A5 JP2001530327A JP2001530327A JP2003511450A5 JP 2003511450 A5 JP2003511450 A5 JP 2003511450A5 JP 2001530327 A JP2001530327 A JP 2001530327A JP 2001530327 A JP2001530327 A JP 2001530327A JP 2003511450 A5 JP2003511450 A5 JP 2003511450A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridin
- imidazo
- butyl
- amine
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920006395 saturated elastomer Polymers 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 12
- 150000002527 isonitriles Chemical class 0.000 description 11
- 238000006467 substitution reaction Methods 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 8
- 125000001072 heteroaryl group Chemical group 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- -1 7-methyl-2-pyridin-3-yl-imidazo [1,2-a] pyridin-3-yl Chemical group 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 4
- 206010008120 Cerebral ischaemia Diseases 0.000 description 4
- 208000023105 Huntington disease Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 206010065390 Inflammatory pain Diseases 0.000 description 4
- 201000009906 Meningitis Diseases 0.000 description 4
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 4
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 4
- 208000018737 Parkinson disease Diseases 0.000 description 4
- 206010040070 Septic Shock Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 201000006417 multiple sclerosis Diseases 0.000 description 4
- 230000036303 septic shock Effects 0.000 description 4
- 201000006474 Brain Ischemia Diseases 0.000 description 3
- 208000019695 Migraine disease Diseases 0.000 description 3
- 150000003927 aminopyridines Chemical class 0.000 description 3
- 206010008118 cerebral infarction Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010027599 migraine Diseases 0.000 description 3
- LNTHINXYEPSOKT-UHFFFAOYSA-N n-tert-butyl-2,5,7-trimethylimidazo[1,2-a]pyridin-3-amine Chemical compound C1=C(C)C=C(C)N2C(NC(C)(C)C)=C(C)N=C21 LNTHINXYEPSOKT-UHFFFAOYSA-N 0.000 description 3
- PILXZSKVZNJVJB-UHFFFAOYSA-N n-tert-butyl-2,7-dimethylimidazo[1,2-a]pyridin-3-amine Chemical compound C1=C(C)C=CN2C(NC(C)(C)C)=C(C)N=C21 PILXZSKVZNJVJB-UHFFFAOYSA-N 0.000 description 3
- KUPJGEBCLOKTAI-UHFFFAOYSA-N n-tert-butyl-2-cyclohexyl-5,7-dimethylimidazo[1,2-a]pyridin-3-amine Chemical compound N1=C2C=C(C)C=C(C)N2C(NC(C)(C)C)=C1C1CCCCC1 KUPJGEBCLOKTAI-UHFFFAOYSA-N 0.000 description 3
- AVUXSWKQTDMSKC-UHFFFAOYSA-N n-tert-butyl-2-cyclohexyl-7-methylimidazo[1,2-a]pyridin-3-amine Chemical compound N1=C2C=C(C)C=CN2C(NC(C)(C)C)=C1C1CCCCC1 AVUXSWKQTDMSKC-UHFFFAOYSA-N 0.000 description 3
- YZGFPSZQJDPTGW-UHFFFAOYSA-N n-tert-butyl-7-methylimidazo[1,2-a]pyridin-3-amine Chemical class C1=C(C)C=CN2C(NC(C)(C)C)=CN=C21 YZGFPSZQJDPTGW-UHFFFAOYSA-N 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- NNGDTFNYWWYMKI-UHFFFAOYSA-N 3-[3-(tert-butylamino)-5,7-dimethylimidazo[1,2-a]pyridin-2-yl]phenol Chemical compound N1=C2C=C(C)C=C(C)N2C(NC(C)(C)C)=C1C1=CC=CC(O)=C1 NNGDTFNYWWYMKI-UHFFFAOYSA-N 0.000 description 2
- UQMMDAXQSRVVDM-UHFFFAOYSA-N 3-[3-(tert-butylamino)-7-methylimidazo[1,2-a]pyridin-2-yl]phenol Chemical compound N1=C2C=C(C)C=CN2C(NC(C)(C)C)=C1C1=CC=CC(O)=C1 UQMMDAXQSRVVDM-UHFFFAOYSA-N 0.000 description 2
- DXGSPAYUJRCIKT-UHFFFAOYSA-N 5-[3-(tert-butylamino)-5,7-dimethylimidazo[1,2-a]pyridin-2-yl]furan-2-carboxylic acid Chemical compound N1=C2C=C(C)C=C(C)N2C(NC(C)(C)C)=C1C1=CC=C(C(O)=O)O1 DXGSPAYUJRCIKT-UHFFFAOYSA-N 0.000 description 2
- RCQFFBBGAATMLI-UHFFFAOYSA-N 5-[3-(tert-butylamino)-7-methylimidazo[1,2-a]pyridin-2-yl]thiophene-2-carboxylic acid Chemical compound N1=C2C=C(C)C=CN2C(NC(C)(C)C)=C1C1=CC=C(C(O)=O)S1 RCQFFBBGAATMLI-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- XBIJCAKRLAMAPN-UHFFFAOYSA-N [5-[3-(tert-butylamino)-7-methylimidazo[1,2-a]pyridin-2-yl]furan-2-yl]methanol Chemical compound N1=C2C=C(C)C=CN2C(NC(C)(C)C)=C1C1=CC=C(CO)O1 XBIJCAKRLAMAPN-UHFFFAOYSA-N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- DUUHRRDRKOEUSK-UHFFFAOYSA-N n-tert-butyl-2-(furan-2-yl)-5,7-dimethylimidazo[1,2-a]pyridin-3-amine Chemical compound N1=C2C=C(C)C=C(C)N2C(NC(C)(C)C)=C1C1=CC=CO1 DUUHRRDRKOEUSK-UHFFFAOYSA-N 0.000 description 2
- GAOXLBQDTVDEJH-UHFFFAOYSA-N n-tert-butyl-2-(furan-2-yl)-7-methylimidazo[1,2-a]pyridin-3-amine Chemical compound N1=C2C=C(C)C=CN2C(NC(C)(C)C)=C1C1=CC=CO1 GAOXLBQDTVDEJH-UHFFFAOYSA-N 0.000 description 2
- LYCYZJPXXHLUGQ-UHFFFAOYSA-N n-tert-butyl-2-[5-(1,3-dioxolan-2-yl)furan-2-yl]-7-methylimidazo[1,2-a]pyridin-3-amine Chemical compound N1=C2C=C(C)C=CN2C(NC(C)(C)C)=C1C(O1)=CC=C1C1OCCO1 LYCYZJPXXHLUGQ-UHFFFAOYSA-N 0.000 description 2
- MMWRUWSLSMDDMI-UHFFFAOYSA-N n-tert-butyl-7-methyl-2-naphthalen-1-ylimidazo[1,2-a]pyridin-3-amine Chemical compound C1=CC=C2C(C3=C(NC(C)(C)C)N4C=CC(=CC4=N3)C)=CC=CC2=C1 MMWRUWSLSMDDMI-UHFFFAOYSA-N 0.000 description 2
- XKXCEJQFBQELLH-UHFFFAOYSA-N n-tert-butyl-7-methyl-2-phenylimidazo[1,2-a]pyridin-3-amine Chemical compound N1=C2C=C(C)C=CN2C(NC(C)(C)C)=C1C1=CC=CC=C1 XKXCEJQFBQELLH-UHFFFAOYSA-N 0.000 description 2
- KLJVZHQAYPDCRK-UHFFFAOYSA-N n-tert-butyl-7-methyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-amine Chemical compound N1=C2C=C(C)C=CN2C(NC(C)(C)C)=C1C1=CC=CC=N1 KLJVZHQAYPDCRK-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000008673 Persea americana Nutrition 0.000 description 1
- 240000002426 Persea americana var. drymifolia Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- MKBVTTATIPGGJD-UHFFFAOYSA-N n-tert-butyl-7-methyl-2-pyridin-3-ylimidazo[1,2-a]pyridin-3-amine Chemical compound N1=C2C=C(C)C=CN2C(NC(C)(C)C)=C1C1=CC=CN=C1 MKBVTTATIPGGJD-UHFFFAOYSA-N 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000010490 three component reaction Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19948434A DE19948434A1 (de) | 1999-10-08 | 1999-10-08 | Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine |
| DE19948434.1 | 1999-10-08 | ||
| PCT/EP2000/009791 WO2001027109A2 (de) | 1999-10-08 | 2000-10-06 | Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridin-3-yl)-amin-derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003511450A JP2003511450A (ja) | 2003-03-25 |
| JP2003511450A5 true JP2003511450A5 (enExample) | 2007-09-27 |
Family
ID=7924888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001530327A Pending JP2003511450A (ja) | 1999-10-08 | 2000-10-06 | ｔ−ブチル−（７−メチル−イミダゾ［１，２−ａ］ピリジン−３−イル）−アミン誘導体 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6703404B2 (enExample) |
| EP (1) | EP1218378B1 (enExample) |
| JP (1) | JP2003511450A (enExample) |
| KR (1) | KR100793619B1 (enExample) |
| CN (1) | CN1208336C (enExample) |
| AR (2) | AR025959A1 (enExample) |
| AT (1) | ATE238304T1 (enExample) |
| AU (2) | AU7419900A (enExample) |
| BR (1) | BR0014827A (enExample) |
| CA (1) | CA2386804A1 (enExample) |
| CO (2) | CO5210861A1 (enExample) |
| CZ (1) | CZ20021241A3 (enExample) |
| DE (2) | DE19948434A1 (enExample) |
| DK (1) | DK1218378T3 (enExample) |
| ES (1) | ES2198355T3 (enExample) |
| HK (1) | HK1047749B (enExample) |
| HU (1) | HUP0203545A3 (enExample) |
| IL (3) | IL148997A0 (enExample) |
| MX (1) | MXPA02003546A (enExample) |
| NO (1) | NO20021564L (enExample) |
| NZ (1) | NZ518438A (enExample) |
| PE (2) | PE20010632A1 (enExample) |
| PL (1) | PL355109A1 (enExample) |
| PT (1) | PT1218378E (enExample) |
| RU (1) | RU2002110281A (enExample) |
| SK (1) | SK4622002A3 (enExample) |
| WO (2) | WO2001027119A2 (enExample) |
| ZA (2) | ZA200203579B (enExample) |
Families Citing this family (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083966A (en) | 1998-08-31 | 2000-07-04 | University Of Florida | Thiazoline acid derivatives |
| CN1585639A (zh) | 1998-09-21 | 2005-02-23 | 佛罗里达大学研究基金会 | 抗疟疾制剂 |
| US6380228B1 (en) | 2000-04-10 | 2002-04-30 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| DE10043845A1 (de) * | 2000-09-06 | 2002-03-14 | Gruenenthal Gmbh | Verfahren zur Messung der Aktivität der NO-Synthase |
| DE10050663A1 (de) * | 2000-10-13 | 2002-04-18 | Gruenenthal Gmbh | Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung |
| EP1343785A2 (de) * | 2000-12-13 | 2003-09-17 | Basf Aktiengesellschaft | Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel |
| DE10117183A1 (de) * | 2001-04-05 | 2002-10-10 | Gruenenthal Gmbh | Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel |
| DE10117184A1 (de) * | 2001-04-05 | 2002-10-17 | Gruenenthal Gmbh | Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen |
| DE10132726A1 (de) * | 2001-07-05 | 2003-02-27 | Gruenenthal Gmbh | Verwendung von substituierten gamma-Lactonverbindungen als Arzneimittel |
| KR20040099324A (ko) | 2002-03-13 | 2004-11-26 | 유로-셀티큐 에스.에이. | 아릴 치환된 피리미딘 및 이것의 용도 |
| IL164703A0 (en) | 2002-04-19 | 2005-12-18 | Cellular Genomics Inc | ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof |
| US20050197435A1 (en) * | 2002-06-14 | 2005-09-08 | Dotson Darin L. | Polymer additive compositions for bimolecular nucleation in thermoplastics |
| AU2003270489A1 (en) | 2002-09-09 | 2004-03-29 | Cellular Genomics, Inc. | 6-ARYL-IMIDAZO(1,2-a)PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF |
| DE10246890A1 (de) * | 2002-10-08 | 2004-04-22 | Grünenthal GmbH | Substituierte C-Imidazo[1,2-alpyridin-3-yl-methylamine |
| WO2004058755A2 (en) * | 2002-12-24 | 2004-07-15 | Biofocus Plc | Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors |
| US7160885B2 (en) | 2003-02-10 | 2007-01-09 | Cgi Pharmaceuticals, Inc. | Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity |
| WO2005014599A1 (en) | 2003-06-04 | 2005-02-17 | Cellular Genomics, Inc. | Imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton’s tyrosine kinase by such compounds |
| US7393848B2 (en) | 2003-06-30 | 2008-07-01 | Cgi Pharmaceuticals, Inc. | Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds |
| US7259164B2 (en) | 2003-08-11 | 2007-08-21 | Cgi Pharmaceuticals, Inc. | Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity |
| WO2005034949A1 (en) | 2003-09-09 | 2005-04-21 | University Of Florida | Desferrithiocin derivatives and their use as iron chelators |
| DE102004021716A1 (de) * | 2004-04-30 | 2005-12-01 | Grünenthal GmbH | Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen |
| DE102004044884A1 (de) | 2004-09-14 | 2006-05-24 | Grünenthal GmbH | Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen |
| CA2581454A1 (en) | 2004-09-23 | 2006-03-30 | Reddy Us Therapeutics, Inc. | Novel pyrimidine compounds, process for their preparation and compositions containing them |
| PL1866296T3 (pl) | 2005-04-04 | 2017-05-31 | University Of Florida Research Foundation, Inc. | Polieterowe analogi desferritiocyny |
| DE102005016547A1 (de) * | 2005-04-08 | 2006-10-12 | Grünenthal GmbH | Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln |
| WO2007024294A2 (en) | 2005-05-03 | 2007-03-01 | Cgi Pharmaceuticals, Inc. | Certain substituted ureas, as modulators of kinase activity |
| MX2007014510A (es) | 2005-05-20 | 2008-02-05 | Array Biopharma Inc | Compuestos inhibidores de raf y metodos de uso de los mismos. |
| US7855289B2 (en) | 2005-08-04 | 2010-12-21 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US8093401B2 (en) | 2005-08-04 | 2012-01-10 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US8088928B2 (en) | 2005-08-04 | 2012-01-03 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| AU2006278504B2 (en) | 2005-08-04 | 2013-01-17 | Sirtris Pharmaceuticals, Inc. | Imidazopyridine derivatives as sirtuin modulating agents |
| JP2009507032A (ja) | 2005-09-02 | 2009-02-19 | アボット・ラボラトリーズ | 新規なイミダゾ系複素環 |
| EP1973545B1 (en) | 2005-12-23 | 2013-01-30 | Ariad Pharmaceuticals, Inc. | Bicyclic heteroaryl compounds |
| DE102006011574A1 (de) * | 2006-03-10 | 2007-10-31 | Grünenthal GmbH | Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln |
| TWI409267B (zh) | 2006-03-17 | 2013-09-21 | Ambit Biosciences Corp | 治療疾病用之咪唑并噻唑化合物 |
| CA2680592C (en) | 2007-03-15 | 2016-07-05 | University Of Florida Research Foundation, Inc. | Desferrithiocin polyether analogues and uses thereof in treating pathological conditions |
| WO2008134553A1 (en) * | 2007-04-26 | 2008-11-06 | Xenon Pharmaceuticals Inc. | Methods of using bicyclic compounds in treating sodium channel-mediated diseases |
| GB0708188D0 (en) * | 2007-04-27 | 2007-06-06 | Merck Sharp & Dohme | Therapeutic compounds |
| CL2008001822A1 (es) | 2007-06-20 | 2009-03-13 | Sirtris Pharmaceuticals Inc | Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras. |
| TW200918542A (en) | 2007-06-20 | 2009-05-01 | Sirtris Pharmaceuticals Inc | Sirtuin modulating compounds |
| DE102007040336A1 (de) * | 2007-08-27 | 2009-03-05 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen |
| KR101572701B1 (ko) | 2007-09-19 | 2015-11-27 | 암비트 바이오사이언시즈 코포레이션 | Ｎ-(5-ｔｅｒｔ-부틸-이속사졸-3-일)-Ｎ'-[4-[7-(2-모르폴린-4-일-에톡시)이미다조[2,1-Ｂ][1,3]벤조티아졸-2-일]페닐]우레아를 포함하는 고체 형태, 그의 조성물 및 그의 용도 |
| US20090221612A1 (en) | 2008-02-13 | 2009-09-03 | Mitchell Scott A | Certain substituted amides, method of making, and method of use thereof |
| ES2396126T3 (es) * | 2008-04-15 | 2013-02-19 | Eisai R&D Management Co., Ltd. | Compuesto de 3-fenilpirazol[5,1-b]tiazol |
| WO2010032195A1 (en) | 2008-09-16 | 2010-03-25 | Csir | Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors |
| US8450321B2 (en) | 2008-12-08 | 2013-05-28 | Gilead Connecticut, Inc. | 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor |
| KR101745732B1 (ko) | 2008-12-08 | 2017-06-12 | 질레드 코네티컷 인코포레이티드 | 이미다조피라진 ｓｙｋ 억제제 |
| MX2011006094A (es) | 2008-12-08 | 2011-11-29 | Gilead Connecticut Inc | Inhibidores de imidazopirazina syk. |
| CN102388054B (zh) | 2008-12-19 | 2015-03-04 | 西特里斯药业公司 | 噻唑并吡啶沉默调节蛋白调节剂的化合物 |
| AR078521A1 (es) * | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
| BR112012022943A2 (pt) | 2010-03-11 | 2018-06-05 | Gilead Connecticut Inc | inibidores de syk de imidazopiridnas |
| KR102111176B1 (ko) | 2011-12-16 | 2020-05-15 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 4'-데스페리티오신 유사체의 용도 |
| CN104540835B (zh) | 2012-04-26 | 2017-08-08 | 百时美施贵宝公司 | 用于治疗血小板聚集的作为蛋白酶激活受体4(par4)抑制剂的咪唑并噻二唑衍生物 |
| WO2013163241A1 (en) | 2012-04-26 | 2013-10-31 | Bristol-Myers Squibb Company | Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
| TWI572605B (zh) | 2012-04-26 | 2017-03-01 | 必治妥美雅史谷比公司 | 血小板聚集之抑制劑 |
| BR112015010469A2 (pt) * | 2012-11-14 | 2017-07-11 | Hoffmann La Roche | derivados de imidazopiridina |
| PT3027171T (pt) | 2013-07-30 | 2020-06-18 | Gilead Connecticut Inc | Formulação de inibidores da syk |
| MX2016001304A (es) | 2013-07-30 | 2016-04-07 | Gilead Connecticut Inc | Polimorfo de inhibidores de syk. |
| EP3071201A4 (en) | 2013-11-22 | 2017-04-26 | University of Florida Research Foundation, Inc. | Desferrithiocin analogs and uses thereof |
| SG11201603050TA (en) | 2013-12-04 | 2016-05-30 | Gilead Sciences Inc | Methods for treating cancers |
| TWI735853B (zh) | 2013-12-23 | 2021-08-11 | 美商克洛諾斯生技有限公司 | 脾酪胺酸激酶抑制劑 |
| US9290505B2 (en) | 2013-12-23 | 2016-03-22 | Gilead Sciences, Inc. | Substituted imidazo[1,2-a]pyrazines as Syk inhibitors |
| DK3105226T3 (da) | 2014-02-13 | 2019-10-14 | Incyte Corp | Cyclopropylaminer som lsd1-inhibitorer |
| EP3105219B9 (en) | 2014-02-13 | 2018-10-03 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
| PT3105218T (pt) | 2014-02-13 | 2019-12-05 | Incyte Corp | Ciclopropilaminas como inibidores de lsd1 |
| US9527835B2 (en) | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
| US9617279B1 (en) | 2014-06-24 | 2017-04-11 | Bristol-Myers Squibb Company | Imidazooxadiazole compounds |
| US9598419B1 (en) | 2014-06-24 | 2017-03-21 | Universite De Montreal | Imidazotriazine and imidazodiazine compounds |
| TWI687419B (zh) | 2014-07-10 | 2020-03-11 | 美商英塞特公司 | 作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪 |
| WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
| TW201613925A (en) | 2014-07-10 | 2016-04-16 | Incyte Corp | Imidazopyrazines as LSD1 inhibitors |
| US9758523B2 (en) | 2014-07-10 | 2017-09-12 | Incyte Corporation | Triazolopyridines and triazolopyrazines as LSD1 inhibitors |
| MX2017000610A (es) | 2014-07-14 | 2017-04-27 | Gilead Sciences Inc | Metodos combinados para tratar canceres. |
| EP3626720A1 (en) | 2015-04-03 | 2020-03-25 | Incyte Corporation | Heterocyclic compounds as lsd1 inhibitors |
| KR20170140306A (ko) | 2015-04-27 | 2017-12-20 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 대사적으로 프로그램화된 금속 킬레이트화제 및 그의 용도 |
| KR102710120B1 (ko) | 2015-08-12 | 2024-09-27 | 인사이트 홀딩스 코포레이션 | Lsd1 저해제의 염 |
| PE20190377A1 (es) | 2016-04-22 | 2019-03-08 | Incyte Corp | Formulaciones de un inhibidor de lsd 1 |
| WO2019014514A1 (en) * | 2017-07-14 | 2019-01-17 | University Of Massachusetts | HETEROCYCLIC COMPOUNDS AND USES THEREOF |
| CN115028640A (zh) | 2017-08-25 | 2022-09-09 | 吉利德科学公司 | Syk抑制剂的多晶型物 |
| CA3075813A1 (en) * | 2017-10-04 | 2019-04-11 | Dana-Farber Cancer Institute, Inc. | Small molecule inhibition of transcription factor sall4 and uses thereof |
| US10968200B2 (en) | 2018-08-31 | 2021-04-06 | Incyte Corporation | Salts of an LSD1 inhibitor and processes for preparing the same |
| KR20210131372A (ko) | 2019-02-22 | 2021-11-02 | 크로노스 바이오, 인코포레이티드 | Syk 억제제로서의 축합된 피라진의 고체 형태 |
| WO2024220541A1 (en) * | 2023-04-18 | 2024-10-24 | Kallyope, Inc. | Nk3 modulators and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3489755A (en) * | 1966-08-03 | 1970-01-13 | Pfizer & Co C | Imidazo (1,2-b) pyridazines |
| FR2463774A1 (fr) * | 1979-08-21 | 1981-02-27 | Yamanouchi Pharma Co Ltd | Derives du 2-phenylimidazo(2,1-b)benzothiazole |
| DE3269604D1 (en) * | 1981-06-26 | 1986-04-10 | Schering Corp | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
| EP0266890A1 (en) * | 1986-10-07 | 1988-05-11 | Yamanouchi Pharmaceutical Co. Ltd. | Imidazopyridine derivatives, their production, and pharmaceutical compositions containing them |
| FR2638161B1 (fr) * | 1988-10-24 | 1991-01-11 | Centre Nat Rech Scient | Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
| JPH08333258A (ja) * | 1994-12-14 | 1996-12-17 | Japan Tobacco Inc | チアジン又はチアゼピン誘導体及びそれら化合物を含有してなる一酸化窒素合成酵素阻害剤 |
| GB9506188D0 (en) * | 1995-03-27 | 1995-05-17 | Fujisawa Pharmaceutical Co | Amidine derivatives |
| US5908842A (en) * | 1995-12-08 | 1999-06-01 | Merck & Co., Inc. | Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase |
| WO1998006724A1 (en) * | 1996-08-09 | 1998-02-19 | Yamanouchi Pharmaceutical Co., Ltd. | Metabotropic glutamate receptor agonists |
| AUPP278498A0 (en) * | 1998-04-03 | 1998-04-30 | Australian Nuclear Science & Technology Organisation | Peripheral benzodiazepine receptor binding agents |
-
1999
- 1999-10-08 DE DE19948434A patent/DE19948434A1/de not_active Withdrawn
-
2000
- 2000-09-18 WO PCT/EP2000/009098 patent/WO2001027119A2/de not_active Ceased
- 2000-09-18 IL IL14899700A patent/IL148997A0/xx not_active IP Right Cessation
- 2000-09-18 AU AU74199/00A patent/AU7419900A/en not_active Abandoned
- 2000-10-02 CO CO00074640A patent/CO5210861A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105250A patent/AR025959A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105251A patent/AR025960A1/es not_active Application Discontinuation
- 2000-10-06 IL IL14899900A patent/IL148999A0/xx active IP Right Grant
- 2000-10-06 SK SK462-2002A patent/SK4622002A3/sk unknown
- 2000-10-06 NZ NZ518438A patent/NZ518438A/en not_active IP Right Cessation
- 2000-10-06 CN CNB008167079A patent/CN1208336C/zh not_active Expired - Fee Related
- 2000-10-06 EP EP00969439A patent/EP1218378B1/de not_active Expired - Lifetime
- 2000-10-06 PT PT00969439T patent/PT1218378E/pt unknown
- 2000-10-06 PE PE2000001063A patent/PE20010632A1/es not_active Application Discontinuation
- 2000-10-06 DE DE50001911T patent/DE50001911D1/de not_active Expired - Lifetime
- 2000-10-06 MX MXPA02003546A patent/MXPA02003546A/es active IP Right Grant
- 2000-10-06 WO PCT/EP2000/009791 patent/WO2001027109A2/de not_active Ceased
- 2000-10-06 HU HU0203545A patent/HUP0203545A3/hu unknown
- 2000-10-06 BR BR0014827-0A patent/BR0014827A/pt not_active IP Right Cessation
- 2000-10-06 JP JP2001530327A patent/JP2003511450A/ja active Pending
- 2000-10-06 CA CA002386804A patent/CA2386804A1/en not_active Abandoned
- 2000-10-06 KR KR1020027004518A patent/KR100793619B1/ko not_active Expired - Fee Related
- 2000-10-06 ES ES00969439T patent/ES2198355T3/es not_active Expired - Lifetime
- 2000-10-06 CO CO00076179A patent/CO5251429A1/es not_active Application Discontinuation
- 2000-10-06 PL PL00355109A patent/PL355109A1/xx not_active IP Right Cessation
- 2000-10-06 AT AT00969439T patent/ATE238304T1/de active
- 2000-10-06 CZ CZ20021241A patent/CZ20021241A3/cs unknown
- 2000-10-06 DK DK00969439T patent/DK1218378T3/da active
- 2000-10-06 AU AU79153/00A patent/AU780526B2/en not_active Ceased
- 2000-10-06 RU RU2002110281/04A patent/RU2002110281A/ru not_active Application Discontinuation
- 2000-10-06 PE PE2000001062A patent/PE20010706A1/es not_active Application Discontinuation
- 2000-10-06 HK HK02109385.2A patent/HK1047749B/zh not_active IP Right Cessation
-
2002
- 2002-04-03 NO NO20021564A patent/NO20021564L/no not_active Application Discontinuation
- 2002-04-04 IL IL148999A patent/IL148999A/en not_active IP Right Cessation
- 2002-04-08 US US10/117,339 patent/US6703404B2/en not_active Expired - Fee Related
- 2002-05-06 ZA ZA200203579A patent/ZA200203579B/xx unknown
- 2002-05-06 ZA ZA200203581A patent/ZA200203581B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003511450A5 (enExample) | ||
| DK2464232T3 (en) | INDAZOLE INHIBITORS OF THE WNT SIGNAL ROAD AND THERAPEUTIC APPLICATIONS THEREOF | |
| KR100793619B1 (ko) | 3급-부틸-(7-메틸-이미다조[1,2-ａ]피리딘-3-일)-아민 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 | |
| CN104546846B (zh) | 1H‑吡唑并[3,4‑b]吡啶及其治疗应用 | |
| CN102712607B (zh) | 作为具有治疗效用的受体调节剂的化合物 | |
| CA2661166A1 (en) | Compounds and methods for inhibiting the interaction of bcl proteins with binding partners | |
| JP2007514737A (ja) | 新規オキサゾリジノン誘導体 | |
| JP2018532698A (ja) | カルボキシ置換（ヘテロ）芳香環誘導体並びにその調製方法及び使用 | |
| CN101448506A (zh) | 通过抑制有丝分裂酶激酶治疗癌症的吡咯并三嗪衍生物 | |
| JP6130600B2 (ja) | トリサイクリックベンズオキサボロール化合物、その製造方法および用途 | |
| KR20130083389A (ko) | 야누스 키나아제 억제제로서 헤테로사이클릭 화합물 | |
| DE10010067A1 (de) | Neue Imidazotriazinone und ihre Verwendung | |
| EP1773835B1 (fr) | Derives de pyrido-pyrido-pyrimidine, leur preparation, leur application dans le traitement du cancer | |
| EP1575960B1 (fr) | Derives de 1,4-diazabicyclo¬3.2.2 nonanecarboxamides, leur preparation et leur application en therapeutique ayant trait au dysfonctionnement des recepteurs nicotiniques | |
| EP2636672B1 (en) | Imidazole derivatives and preparation method and use thereof | |
| EP1902054B1 (fr) | Derives de pyrido[2,3-d]pyrimidine, leur preparation, leur application en therapeutique | |
| CN103328492A (zh) | 作为受体调节剂具有疗效的新型化合物 | |
| JP2003513914A (ja) | 癌の処置のための腫瘍崩壊薬の組み合わせ | |
| KR20190140977A (ko) | 인돌리노벤조다이아제핀 유도체를 제조하는 방법 | |
| CN102603755B (zh) | 一类具有协同氟康唑抗耐药真菌作用的化合物 | |
| HUE027903T2 (hu) | A 6,7-dihidro-3H-oxazolo[3,4-a]pirazin-5,8-dion származékai | |
| EA030709B1 (ru) | Производное фенантролинфосфоновой кислоты и способ его получения и применения | |
| KR102640385B1 (ko) | 고혈압 및/또는 폐 섬유증 치료용 조성물 | |
| JPS5967266A (ja) | 置換ビニルカルボン酸誘導体 | |
| JP2003516972A (ja) | Ｎ−（１−フェニルエチル）−５−フェニル−イミダゾール−２−アミン化合物と、その組成物及び使用 |